BRPI0808889A2 - Comprimido desintegrante oral - Google Patents

Comprimido desintegrante oral

Info

Publication number
BRPI0808889A2
BRPI0808889A2 BRPI0808889-6A2A BRPI0808889A BRPI0808889A2 BR PI0808889 A2 BRPI0808889 A2 BR PI0808889A2 BR PI0808889 A BRPI0808889 A BR PI0808889A BR PI0808889 A2 BRPI0808889 A2 BR PI0808889A2
Authority
BR
Brazil
Prior art keywords
disinterranting
pill
oral
oral disinterranting
disinterranting pill
Prior art date
Application number
BRPI0808889-6A2A
Other languages
English (en)
Inventor
Makoto Matsuoka
Hiroyuki Nishii
Maki Kawamura
Original Assignee
Dainippon Sumitomo Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Sumitomo Pharma Co filed Critical Dainippon Sumitomo Pharma Co
Publication of BRPI0808889A2 publication Critical patent/BRPI0808889A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0808889-6A2A 2007-03-13 2008-03-12 Comprimido desintegrante oral BRPI0808889A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007063913 2007-03-13
PCT/JP2008/054529 WO2008120548A2 (ja) 2007-03-13 2008-03-12 口腔内崩壊錠

Publications (1)

Publication Number Publication Date
BRPI0808889A2 true BRPI0808889A2 (pt) 2014-11-11

Family

ID=39808792

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0808889-6A2A BRPI0808889A2 (pt) 2007-03-13 2008-03-12 Comprimido desintegrante oral

Country Status (9)

Country Link
US (2) US8778392B2 (pt)
EP (1) EP2133096A4 (pt)
JP (7) JP5537927B2 (pt)
KR (1) KR20090119993A (pt)
CN (1) CN101646461A (pt)
BR (1) BRPI0808889A2 (pt)
CA (1) CA2680536A1 (pt)
RU (1) RU2478375C2 (pt)
WO (1) WO2008120548A2 (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2133096A4 (en) * 2007-03-13 2011-11-16 Dainippon Sumitomo Pharma Co IN THE MOUTHING TABLET
FR2933299B1 (fr) * 2008-07-04 2012-02-03 Roquette Freres Mannitol orodispersible
US20110229570A1 (en) * 2008-11-25 2011-09-22 Masaaki Sugimoto Orally rapidly disintegrating tablet and process for producing same
TWI400089B (zh) 2009-11-24 2013-07-01 Nippon Soda Co 羥烷基纖維素微粒子
JP5680898B2 (ja) * 2010-08-10 2015-03-04 京都薬品工業株式会社 苦味を抑制した速崩壊錠
WO2012029838A1 (ja) * 2010-08-31 2012-03-08 協和発酵キリン株式会社 口腔内崩壊錠
EP2646003B1 (en) * 2010-12-02 2020-06-03 Adare Pharmaceuticals, Inc. Rapidly dispersing granules, orally disintegrating tablets and methods
MX2013008314A (es) * 2011-01-17 2013-09-26 Takeda Pharmaceutical Tableta dispersable en forma oral.
US8426461B2 (en) 2011-01-17 2013-04-23 Takeda Pharmaceutical Company Limited Orally dispersible tablet
JP5710301B2 (ja) * 2011-02-08 2015-04-30 富士フイルム株式会社 口腔内崩壊型錠及びその製造方法
JP6004882B2 (ja) * 2012-10-15 2016-10-12 三菱商事フードテック株式会社 圧縮成形に用いるためのマンニトール賦形剤及びこれを含有する錠剤
MA38974B2 (fr) * 2013-10-17 2020-11-30 Bayer Pharma AG Formes galéniques pharmaceutiques contenant du sodium 1-[6-{morpholine-4-yl)pyrimidine-4-yl]-4-(1h-1,2,3- triazol-1-yl)-1h-pyrazol-5-olate
KR20160108828A (ko) * 2013-11-11 2016-09-20 임팩스 라보라토리즈, 인코포레이티드 신속하게 붕괴되는 제형 및 사용 방법
JP6926404B2 (ja) * 2015-06-12 2021-08-25 ゼリア新薬工業株式会社 口腔内崩壊錠
CN108289849A (zh) 2015-06-26 2018-07-17 韩国联合制药株式会社 莫沙必利与雷贝拉唑的复合制剂
JP6507272B2 (ja) * 2015-07-27 2019-04-24 ユニケム ラボラトリーズ リミテッド トファシチニブ口腔内崩壊錠
EP3406241A4 (en) * 2016-01-18 2019-06-26 Daicel Corporation INTRAORAL RESISTANT DISTILLANT SOLUBLE PREPARATION, METHOD FOR THE MANUFACTURE THEREOF, AND POWDER COMPOSITION USED IN THE SAID MANUFACTURING METHOD
JP6496085B2 (ja) * 2016-06-16 2019-04-03 東和薬品株式会社 口腔内崩壊錠
JP7182356B2 (ja) * 2017-07-05 2022-12-02 日本ケミファ株式会社 口腔内崩壊錠及びその製造方法
JP2020105173A (ja) * 2018-12-27 2020-07-09 日本ケミファ株式会社 ２種以上の薬物を含有する口腔内崩壊錠及びその製造方法
WO2021095092A1 (ja) * 2019-11-11 2021-05-20 大塚製薬株式会社 口腔内崩壊錠
RU2732291C1 (ru) * 2020-02-13 2020-09-15 Открытое акционерное общество "Фармстандарт-Лексредства" (ОАО "Фармстандарт-Лексредства") Лекарственный препарат на основе травы алтея лекарственного для лечения простудных и острых респираторных заболеваний
WO2022103636A1 (en) 2020-11-16 2022-05-19 Orcosa Inc. Improved use of cannabinoids in the treatment of alzheimer's disease
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans
MX2023007601A (es) * 2020-12-23 2023-07-10 Sumitomo Pharma Co Ltd Preparacion solida oral.
GB2636158A (en) 2023-12-01 2025-06-11 Novumgen Ltd An orally disintegrating tablet containing amlodipine or pharmaceutically acceptable salts thereof and the process of preparing the same
CN118845681A (zh) * 2024-07-09 2024-10-29 广东万泰科创药业有限公司 一种苯磺酸氨氯地平口崩片组合物及其制备方法

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01135450A (ja) 1987-11-18 1989-05-29 Honda Motor Co Ltd パレットの回転割出し装置
RU2109509C1 (ru) 1991-12-24 1998-04-27 Яманути Фармасьютикал Ко., Лтд. Композиция для буккального введения лекарственного средства и способ ее получения
JPH09309822A (ja) 1992-02-18 1997-12-02 Nippon Shinyaku Co Ltd 口腔内溶解型速溶錠
JPH09309821A (ja) 1992-02-18 1997-12-02 Nippon Shinyaku Co Ltd 口腔内溶解型速溶錠の製法
US5837285A (en) 1992-02-18 1998-11-17 Nakamichi; Kouichi Fast soluble tablet
HUT75616A (en) 1992-03-17 1997-05-28 Pfizer Method for prooucing porous delivery devices
JPH0971523A (ja) 1995-09-07 1997-03-18 Riyuukakusan:Kk 口腔内で崩壊性の速い錠剤
CN1221398A (zh) 1996-04-16 1999-06-30 拜尔公司 甘露糖醇及其制备
US6235947B1 (en) 1997-04-14 2001-05-22 Takeda Chemical Industries, Ltd. D-mannitol and its preparation
US20010001106A1 (en) 1996-04-16 2001-05-10 Tomohiro Yoshinari D-mannitol and its preparation
JP3126683B2 (ja) * 1996-04-16 2001-01-22 武田薬品工業株式会社 Ｄ−マンニトールおよびその製造法
CA2258159C (en) 1996-06-14 2006-03-21 Kyowa Hakko Kogyo Co., Ltd. Intraorally rapidly disintegrable tablet
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
EP0839526A3 (en) 1996-10-31 1999-01-07 Takeda Chemical Industries, Ltd. Solid pharmaceutical preparation with fast buccal disintegration or dissolution
JPH10182436A (ja) 1996-10-31 1998-07-07 Takeda Chem Ind Ltd 固形医薬製剤
JPH10298062A (ja) 1997-04-24 1998-11-10 Pfizer Pharmaceut Co Ltd 口腔内速溶型錠剤
FR2766089B1 (fr) 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
AU4802099A (en) 1998-07-28 2000-02-21 Takeda Chemical Industries Ltd. Rapidly disintegrable solid preparation
JP4504467B2 (ja) 1998-07-30 2010-07-14 佐藤製薬株式会社 口腔内崩壊性錠剤
FR2785538B1 (fr) * 1998-11-06 2004-04-09 Prographarm Laboratoires Comprime a delitement rapide perfectionne
JP2000273039A (ja) * 1999-01-20 2000-10-03 Taisho Pharmaceut Co Ltd 口腔内崩壊性組成物
US20030026835A1 (en) * 1999-02-15 2003-02-06 Sumitomo Pharmaceuticals Company Limited Tablets disintegrating rapidly in the oral cavity
EP1153616B1 (en) * 1999-02-15 2004-12-01 Sumitomo Pharmaceuticals Company, Limited Tablets quickly disintegrated in the oral cavity
JP2001058944A (ja) 1999-06-18 2001-03-06 Takeda Chem Ind Ltd 速崩壊性固形製剤
EP1203580A4 (en) 1999-06-18 2004-06-30 Takeda Chemical Industries Ltd QUICKLY DISINTERABLE SOLID PREPARATIONS
JP2001122804A (ja) 1999-10-28 2001-05-08 Sato Pharmaceutical Co Ltd リン酸コーンスターチ配合外用医薬組成物
JP3435664B2 (ja) * 1999-12-08 2003-08-11 ヤンセンファーマ株式会社 口腔内速崩壊型錠剤及びその製造方法
DE10003757A1 (de) * 2000-01-28 2001-08-02 Knoll Ag Ibuprofen-Wirkstoffzubereitung
JP4802436B2 (ja) 2000-04-12 2011-10-26 Ｍｓｄ株式会社 口腔内崩壊型組成物及び口腔内崩壊型製剤
AU2001294192A1 (en) * 2000-10-06 2002-04-22 Takeda Chemical Industries Ltd. Solid preparations
JP4284017B2 (ja) * 2000-10-06 2009-06-24 武田薬品工業株式会社 固形製剤
JP4358117B2 (ja) 2001-03-06 2009-11-04 協和発酵キリン株式会社 口腔内速崩壊錠
DE60232496D1 (de) 2001-03-06 2009-07-16 Kyowa Hakko Kirin Co Ltd Tabletten, die in der mundhöhle schnell zerfallen
JP4848558B2 (ja) 2001-05-08 2011-12-28 トーアエイヨー株式会社 塩酸メトホルミン含有速放性錠剤
JP2003034655A (ja) 2001-05-15 2003-02-07 Takeda Chem Ind Ltd 速崩壊性固形製剤
JP2003192695A (ja) 2001-12-27 2003-07-09 National Institute Of Advanced Industrial & Technology アンジオテンシンｉ変換酵素阻害剤
AU2003221326A1 (en) * 2002-03-06 2003-09-16 Kyowa Hakko Kogyo Co., Ltd. Tablets quickly disintegrating in oral cavity
JP4408340B2 (ja) * 2002-03-22 2010-02-03 武田薬品工業株式会社 速崩壊性固形製剤
JP4523265B2 (ja) 2002-11-13 2010-08-11 旭化成ファーマ株式会社 排尿障害治療用口腔内崩壊製剤
JP4475233B2 (ja) * 2003-01-21 2010-06-09 日本新薬株式会社 口腔内速崩性錠剤
CA2514875A1 (en) 2003-02-19 2004-09-02 Biovail Laboratories International Srl Rapid absorption selective 5-ht agonist formulations
US20060115529A1 (en) * 2003-05-07 2006-06-01 Seonghoon Jeong Fast-melting tablets having taste-masking and sustained release properties
CN1565425A (zh) 2003-06-24 2005-01-19 北京康诺伟业医药科技有限责任公司 一种可在口腔中迅速崩解的片剂及其制备方法
JP2006022039A (ja) * 2004-07-08 2006-01-26 Towa Yakuhin Kk 高い安定性を有するシンバスタチン固形製剤
CA2582299A1 (en) 2004-10-05 2006-04-13 Altana Pharma Ag Oral pharmaceutical preparation for proton pump antagonists
JP4509118B2 (ja) * 2004-10-06 2010-07-21 エルメッド エーザイ株式会社 医薬組成物及びその製造方法、並びに医薬組成物におけるジヒドロピリジン系化合物の安定化方法
TW200637564A (en) 2004-12-27 2006-11-01 Kowa Co Orally disintegrable solid preparation comprising povidone-iodine
EP1681048A1 (en) * 2005-01-14 2006-07-19 Krka Tovarna Zdravil, D.D., Novo Mesto Orally disintegrating composition of olanzapine or donepezil
JP2006265242A (ja) 2005-02-28 2006-10-05 Dai Ichi Seiyaku Co Ltd 口腔内速崩壊性医薬用組成物およびその製造方法
JP4214128B2 (ja) 2005-04-27 2009-01-28 大日本住友製薬株式会社 光安定性の向上した組成物
US20100016378A1 (en) 2005-04-28 2010-01-21 Toshio Suzuki Method of preventing dihydropyridine compound from degradation
PE20070698A1 (es) * 2005-11-14 2007-08-17 Teijin Pharma Ltd Comprimido de disgregacion rapida intraoral que contiene hidrocloruro de ambroxol
EP2133096A4 (en) * 2007-03-13 2011-11-16 Dainippon Sumitomo Pharma Co IN THE MOUTHING TABLET
JP4989733B2 (ja) * 2008-02-13 2012-08-01 大日本住友製薬株式会社 口腔内崩壊錠

Also Published As

Publication number Publication date
US9980915B2 (en) 2018-05-29
EP2133096A2 (en) 2009-12-16
JP2017082006A (ja) 2017-05-18
RU2009137794A (ru) 2011-04-20
US20140300025A1 (en) 2014-10-09
EP2133096A4 (en) 2011-11-16
JP5752227B2 (ja) 2015-07-22
CN101646461A (zh) 2010-02-10
JP6092936B2 (ja) 2017-03-08
JP2014055189A (ja) 2014-03-27
US8778392B2 (en) 2014-07-15
CA2680536A1 (en) 2008-10-09
JPWO2008120548A1 (ja) 2010-07-15
WO2008120548A3 (ja) 2008-12-18
KR20090119993A (ko) 2009-11-23
JP5537927B2 (ja) 2014-07-02
RU2478375C2 (ru) 2013-04-10
JP2018058911A (ja) 2018-04-12
JP2020125358A (ja) 2020-08-20
JP2015147812A (ja) 2015-08-20
US20100098756A1 (en) 2010-04-22
WO2008120548A2 (ja) 2008-10-09
JP2019081789A (ja) 2019-05-30

Similar Documents

Publication Publication Date Title
BRPI0808889A2 (pt) Comprimido desintegrante oral
BRPI0820861A2 (pt) Comprimido oral dispersível
LTPA2018005I1 (lt) Farmacinė kompozicija
DK4218732T3 (da) Tabletter omfattende eltrombopag-olamin
BRPI0817927A2 (pt) Comprimidos orodispersiveis
BRPI0808016A2 (pt) Dispositivos ortodônticos
BRPI0820381A2 (pt) Formulações farmacêuticas
DOS2008000026S (es) Confiteria
DK2041139T3 (da) Farmaceutiske forbindelser
DK2182863T3 (da) Åbningsdilatator
BRPI0720100A2 (pt) Implemento para cuidado oral
RU2493831C3 (ru) Фармацевтические композиции
BRPI0812916A2 (pt) Chupeta
EP2176032A4 (en) BACK ARRANGEMENT
BRPI0908114A2 (pt) tabuleta oral de liberação controlada
DK2120884T3 (da) Farmaceutisk sammensætning
DK2194959T3 (da) Skummedygtig mundplejetilberedning
DE502007005910D1 (de) Tablettenabfüllvorrichtung
GB0710439D0 (en) Oral dosage form
PT2209464E (pt) Composição farmacêutica antimalárica
BRPI0821735A2 (pt) Fabricação de tablete
BRPI0812964A2 (pt) Forma de dosagem farmacêutica oral sólida
BRPI0820198A2 (pt) composições farmacêuticas
BRPI0815562A2 (pt) Soluções farmacêuticas orais contendo telbivudina.
EP2156842A4 (en) ORAL COMPOSITION

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2329 DE 25-08-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]